209 related articles for article (PubMed ID: 25944911)
1. Protein Depalmitoylation Is Induced by Wnt5a and Promotes Polarized Cell Behavior.
Wang W; Runkle KB; Terkowski SM; Ekaireb RI; Witze ES
J Biol Chem; 2015 Jun; 290(25):15707-15716. PubMed ID: 25944911
[TBL] [Abstract][Full Text] [Related]
2. Wnt5a signaling induced phosphorylation increases APT1 activity and promotes melanoma metastatic behavior.
Sadeghi RS; Kulej K; Kathayat RS; Garcia BA; Dickinson BC; Brady DC; Witze ES
Elife; 2018 Apr; 7():. PubMed ID: 29648538
[TBL] [Abstract][Full Text] [Related]
3. The depalmitoylase APT1 directs the asymmetric partitioning of Notch and Wnt signaling during cell division.
Stypulkowski E; Asangani IA; Witze ES
Sci Signal; 2018 Jan; 11(511):. PubMed ID: 29295957
[TBL] [Abstract][Full Text] [Related]
4. Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
Endo M; Nishita M; Fujii M; Minami Y
Int Rev Cell Mol Biol; 2015; 314():117-48. PubMed ID: 25619716
[TBL] [Abstract][Full Text] [Related]
5. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase.
Yamamoto H; Oue N; Sato A; Hasegawa Y; Yamamoto H; Matsubara A; Yasui W; Kikuchi A
Oncogene; 2010 Apr; 29(14):2036-46. PubMed ID: 20101234
[TBL] [Abstract][Full Text] [Related]
6. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
[TBL] [Abstract][Full Text] [Related]
7. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.
Jenei V; Sherwood V; Howlin J; Linnskog R; Säfholm A; Axelsson L; Andersson T
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19473-8. PubMed ID: 19901340
[TBL] [Abstract][Full Text] [Related]
8. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.
Yamamoto H; Kitadai Y; Yamamoto H; Oue N; Ohdan H; Yasui W; Kikuchi A
Gastroenterology; 2009 Jul; 137(1):242-52, 252.e1-6. PubMed ID: 19582886
[TBL] [Abstract][Full Text] [Related]
9. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
10. Cell/tissue-tropic functions of Wnt5a signaling in normal and cancer cells.
Nishita M; Enomoto M; Yamagata K; Minami Y
Trends Cell Biol; 2010 Jun; 20(6):346-54. PubMed ID: 20359892
[TBL] [Abstract][Full Text] [Related]
11. Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors.
Witze ES; Litman ES; Argast GM; Moon RT; Ahn NG
Science; 2008 Apr; 320(5874):365-9. PubMed ID: 18420933
[TBL] [Abstract][Full Text] [Related]
12. [Preparation of the recombinant lentiviral expression vector targeting human Wnt5a gene and its inhibitory effect on melanoma cell invasion].
Zhao Y; Miao Y; Chen X; Wang L; Lu F; Liao W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):462-5. PubMed ID: 24796738
[TBL] [Abstract][Full Text] [Related]
13. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
14. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
[TBL] [Abstract][Full Text] [Related]
15. Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathway.
MacMillan CD; Leong HS; Dales DW; Robertson AE; Lewis JD; Chambers AF; Tuck AB
Sci Rep; 2014 Sep; 4():6315. PubMed ID: 25204426
[TBL] [Abstract][Full Text] [Related]
16. Wnt5a uses CD146 as a receptor to regulate cell motility and convergent extension.
Ye Z; Zhang C; Tu T; Sun M; Liu D; Lu D; Feng J; Yang D; Liu F; Yan X
Nat Commun; 2013; 4():2803. PubMed ID: 24335906
[TBL] [Abstract][Full Text] [Related]
17. Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling.
Kurayoshi M; Yamamoto H; Izumi S; Kikuchi A
Biochem J; 2007 Mar; 402(3):515-23. PubMed ID: 17117926
[TBL] [Abstract][Full Text] [Related]
18. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
[TBL] [Abstract][Full Text] [Related]
19. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
Zhu Y; Shen T; Liu J; Zheng J; Zhang Y; Xu R; Sun C; Du J; Chen Y; Gu L
Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
[TBL] [Abstract][Full Text] [Related]
20. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
